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Abstract 
Background: In the last decade canine models have been used extensively to study genetic causes of neurological 
disorders such as epilepsy and Alzheimer’s disease and unravel their pathophysiological pathways. Reverse transcrip-
tion quantitative polymerase chain reaction is a sensitive and inexpensive method to study expression levels of genes 
involved in disease processes. Accurate normalisation with stably expressed so-called reference genes is crucial for 
reliable expression analysis.
Results: Following the minimum information for publication of quantitative real-time PCR experiments precise 
guidelines, the expression of ten frequently used reference genes, namely YWHAZ, HMBS, B2M, SDHA, GAPDH, HPRT, 
RPL13A, RPS5, RPS19 and GUSB was evaluated in seven brain regions (frontal lobe, parietal lobe, occipital lobe, tempo-
ral lobe, thalamus, hippocampus and cerebellum) and whole brain of healthy dogs. The stability of expression varied 
between different brain areas. Using the GeNorm and Normfinder software HMBS, GAPDH and HPRT were the most 
reliable reference genes for whole brain. Furthermore based on GeNorm calculations it was concluded that as little as 
two to three reference genes are sufficient to obtain reliable normalisation, irrespective the brain area.
Conclusions: Our results amend/extend the limited previously published data on canine brain reference genes. 
Despite the excellent expression stability of HMBS, GAPDH and HRPT, the evaluation of expression stability of reference 
genes must be a standard and integral part of experimental design and subsequent data analysis.
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Background
Companion dogs that cohabitate with their owners under 
similar environmental conditions frequently develop the 
same hereditary diseases as people do [1, 2]. For exam-
ple aging dogs may demonstrate cognitive decline with 
distinctive neuropathological features that parallel early 
Alzheimer’s disease [3]. Likewise human and canine pri-
mary epilepsy share many clinical characteristics [4].
Recently Briggs et  al. [5] found that the expression of 
orthologous genes between matched canine and human 
tissues was remarkably similar. Inbreeding in dogs nar-
rows the genetic variation within breeds and works as 
a magnifier to dissect the genetic background of inher-
ited diseases which is one of the reasons for an in-depth 
sequencing of the dog’s genome [6]. As a consequence 
there has been a keen interest in utilising the dog both 
as a pathophysiological and genetic model for common 
human diseases [1, 7]. This has resulted in the discovery 
of novel causative mutations in several disorders, among 
others in hereditary epilepsy [8, 9] and elucidation of the 
pathological pathways involved [10]. An example of the 
latter is the identification of the mutation in HCRTR2 
causing narcolepsy in Doberman Pinschers which led 
to the unravelling of a pathway involved in this disease 
and sleep regulation [11]. Canine brain models have been 
widely used to study epilepsy and Alzheimer’s disease [3, 
4, 12, 13]. These studies are of great significance for both 
human and veterinary medicine.
Knowledge of gene expression is essential for 
understanding how genes regulate both physiologi-
cal and pathological processes at a fundamental level. 
Reverse transcription in combination with quantitative 
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polymerase chain reaction (RT-qPCR) has become the 
method of choice for quantifying mRNA expression in 
biological tissues because of its high sensitivity, accuracy 
and relatively low costs. During such a complex multi-
step procedure experimental errors between samples 
(e.g., differences in initial sample RNA amounts, effi-
ciency of RNA isolation, RNA integrity and efficiency of 
reverse transcription) can easily occur [14, 15]. To cor-
rect for these errors data normalisation is indispensable. 
The most popular normalisation strategy involves the use 
of stably expressed endogenous reference genes to which 
expression of the gene(s) of interest can be related. How-
ever expression of commonly used reference genes has 
been reported to vary between tissues, individuals, spe-
cies, methods used and to be influenced by pathological 
conditions and therapies [16–18]. Dheda et  al. [19] and 
Ohl et al. [20] demonstrated that the outcome of expres-
sion analysis is highly dependent on the reference gene 
chosen. Therefore selection of inappropriate reference 
genes or insufficient numbers of reference genes, result-
ing in erroneous conclusions, poses a major problem in 
expression studies.
To the best of the authors’ knowledge only two papers 
concerning identification of reference genes for the 
canine brain have been published [21, 22]. Unfortunately, 
the results of those studies didn’t correspond with each 
other. This emphasises the need to come up with a nor-
malisation strategy in canine brain tissue that allows 
for the comparison of data and independent replication 
of experiments. The precise minimum information for 
publication of quantitative real-time PCR experiments 
(MIQE) guidelines describe such a strategy [23, 24]. Fol-
lowing these guidelines, the expression of ten frequently 
used reference genes in seven brain regions from seven 
healthy dogs was studied to determine which reference 




Normal brain tissue was obtained as surplus material 
from seven healthy dogs that were euthanised in non-
related experiments approved by the Utrecht Univer-
sity Animal Experiments Committee as required under 
Dutch legislation and according to the University’s 3Rs-
policy. The group included 4 mixed-breeds, 2 Labrador 
Retrievers and 1 Beagle; 4 males 3 females; age ranging 
from 4 months to 9 years.
The brain was removed and dissected immediately 
after death had occurred. Tissue samples from the cere-
bral cortex (frontal lobe, parietal lobe, occipital lobe and 
temporal lobe), thalamus, hippocampus and cerebel-
lum were obtained from each dog and placed in 5–10 
volumes RNA later® stabilisation fluid (Ambion, Austin, 
TX) for 24–48 h. Subsequently supernatant was removed 
and samples were stored at −70 °C until assayed.
Primer design
The following candidate reference genes, represent-
ing different functional classes, were selected: YWHAZ 
(coding for zeta polypeptide), HMBS (for hydroxy-
methylbilane synthase), B2M (for beta-2-microglobulin), 
SDHA (for succinate dehydrogenase complex subunit 
A), GAPDH (for glyceraldehyde-3-phosphate dehydroge-
nase), HPRT (for hypoxanthine guanine phosphoribosyl 
transferase), RPL13A (for ribosomal protein 13A), RPS5 
(for ribosomal protein S5), RPS19 (for ribosomal protein 
S19) and GUSB (for beta-glucuronidase).
Primer design was performed with Oligo Explorer 1.1.0 
software [25]. Forward and reverse primers were posi-
tioned in different exons to reduce the chance of ampli-
fication of genomic DNA where feasible. Details of the 
primers including exonic locations are depicted in Addi-
tional file  1: Table S1. Basic local alignment search tool 
[26] searches were performed to verify specificity of each 
primer.
RNA isolation, reverse transcription and quantitative PCR
Total RNA was isolated from RNA later fixed sam-
ples, using Qiagen RNeasy Mini Kit (Qiagen, Leus-
den, The Netherlands) according to the manufacturer’s 
instructions including an on-column deoxyribonulease 
I (DNase I) treatment. RNA quantity and quality were 
evaluated spectrophotometrically using Nanadrop 
ND-1000 (Isofen Life Sciences, IJsselstein, The Neth-
erlands) and an Agilent BioAnalyzer 2100 (Agilent, 
Palo Alto, CA) respectively. All RNA integrity number 
values, based on 28S and 18S integrity, were above 7.0 
(range 7.0–8.3) indicating good quality RNA. Reverse 
transcription was performed with 50  ng of total RNA 
in a total reaction volume of 20 μl using iScript™ cDNA 
Synthesis Kit (Bio-rad, Veenendaal, The Netherlands) 
containing a mix of both oligo-dT and random hexamer 
primers.
After cDNA synthesis the reactions were diluted ten-
fold and a part of each reaction was pooled and used in 
a fourfold serial dilution to assess the amplification effi-
ciency of each gene. The rest of the reaction was diluted 
fivefold and used as a template to measure the gene 
expression in technical duplicates.
RNA samples were tested for contamination with 
genomic DNA by qPCR of non-reverse-transcribed RNA 
templates (minus RT-controls). Also a no template con-
trol was included containing ultrapure water instead 
of cDNA to test for reaction contaminants and primer 
dimer formation.
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The qPCR reaction was performed on a MyiQ™ quan-
titative PCR machine (Bio Rad). Reactions contained 
12.5  µl of 2×  IQ SYBRGreen SuperMix (Bio Rad), 
400 nM of each primer (Eurogentec), 1 µl cDNA template 
and ultrapure water to a reaction volume of 25 µl.
Cycling conditions were 3  min at 95  °C, followed by 
45 cycles with denaturing template for 20 s at 95 °C, fol-
lowed by 30 s at melting temperature (Tm), and elonga-
tion at 72  °C for 30  s. When the annealing temperature 
(Ta) was higher than 57 °C, the elongation step at 72 °C 
was omitted and extension took place at Ta.
Subsequently, a melt curve, to verify amplification 
of a single product, was generated starting at 65  °C and 
increasing by 1 °C every 30 s to 99 °C.
The amplification efficiency was always between 92 and 
107  %. As the limit of detection (LOD) the Cq-value of 
the highest standard dilution was used and values for the 
measured genes were found to be: GUSB: 32.65, B2M: 
27.18, RPL13: 25.99, RPS19: 27.94, RPS5: 26.89, SDHA: 
26.79, YWHAZ: 25.83, GAPDH: 23.84, HMBS: 32.63, 
HPRT: 27.84. With regard to all the measured genes, 
none of the sample values fell below the LOD value of the 
measured gene.
The DNase treatment and primer locations mini-
mised potential PCR artefacts caused by contaminating 
genomic DNA. Sequencing (Applied Biosystems, BigDye 
Terminator version 3.1) of the amplicon products con-
firmed product specificity.
Data analysis
Data were analysed using GeNorm and NormFinder. 
Both freeware programs have unique properties; a com-
bination of both analyses will produce reliable data. 
GeNorm calculates the stability of expression (M) of one 
gene based on the average pair-wise variation between 
all the studied reference genes. Stepwise elimination of 
the least stable gene finally identifies the two most sta-
ble genes [27]. Furthermore, GeNorm determines the 
optimal number of reference genes by calculating the 
normalisation factor (NF) for a given number of refer-
ence genes (n). Next the pairwise variation (V) between 
the consecutive normalisation factors NFn and NFn+1 is 
defined. The lower V, the smaller the variation, implying 
that adding an extra gene doesn’t significantly improve 
normalisation. A cut-off value of 0.15 for the pairwise 
variation is most often chosen, indicating that the use 
of a set of reference genes with a pairwise variation 
<0.15 results in valid normalisation [14, 20, 24, 27, 28]. 
GeNorm analysis was performed using R (Version 2.12.0, 
Free Software Foundation) [29] and the GeNorm method 
from the SLqPCR package [30].
NormFinder analysis is a model-based approach, which 
calculates the overall variation in expression within 
sample groups of interest (intragroup variation) and the 
variation across the sample groups (intergroup variation) 
for each evaluated reference gene [31]. The combina-
tion of the two variation parameters results in a stability 
value, representing a practical measure of the systematic 
error that will be introduced when using a particular ref-
erence gene. NormFinder calculations were done using 
the NormFinder plug-in for Microsoft Excel [32].
Results
The ten potential reference genes could be amplified in 
all brain regions evaluated. Both RT-minus and water 
controls were negative implying a lack of contaminating 
genomic DNA.
GeNorm analysis determined variable stability of refer-
ence genes in different brain areas (Table 1). The curves 
in Fig. 1 represent the average expression stability (M) of 
remaining reference genes during the step-by-step elimi-
nation of the least stable reference gene in different brain 
regions. A high M value indicates low expression stabil-
ity. In most brain areas all calculated expression stabili-
ties were below 1.0, indicating fairly stable expression of 
the reference genes evaluated. Expression stabilities (M) 
for the average of all evaluated areas (“whole brain”) were 
calculated and also plotted in Fig. 1. GUSB had the high-
est M-value (implying that it is the least stable gene) and 
was therefore excluded first. HMBS and GAPDH turned 
out to be the most stably expressed genes.
The GeNorm program also calculated the minimum 
number of reference genes required for valid normalisa-
tion (Fig. 2). Based on a cut-off value of 0.15 for the pair-
wise variation only two reference genes are sufficient to 
obtain a reliable NF in all evaluated brain regions and the 
average of all areas.
According to the NormFinder program HMBS is the 
most stably expressed reference gene with a stability 
value of 0.005. GAPDH, HPRT, RPS19 and GUSB share 
the second best stability value of 0.007. Therefor the 
best combination of two genes is HMBS with one of the 
above-mentioned genes resulting in a stability value of 
0.004. These results correspond well with the results of 
the GeNorm analysis that identified HMBS and GAPDH 
as the two most stable control genes (Table 2).
Discussion
Gene expression analysis by RT-qPCR has become 
increasingly important in studies trying to disentangle 
the pathogenesis of different disease processes in vari-
ous species. In 2006 and 2007 two papers were published 
evaluating various reference genes in a plethora of canine 
tissues [28, 33]. Unfortunately brain was not included 
in one of these. The first evaluation of reference gene 
expression stability in canine brain was presented by 
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Vage et al. in which differential gene expression in brain 
tissue of aggressive and normal dogs was studied [21]. 
Because of the nature of their studies Vage et al. focussed 
on four brain areas known to be involved in behavioural 
reactions (amygdala, frontal cortex, hypothalamus and 
parietal cortex). To verify cDNA subtraction assays, 
qPCR was performed on nine differentially expressed 
genes and eight different reference genes (ACTB, 
HNRNPH, HPRT1, RPL32, RPS5, TBP, TFRC and TKT) 
were included. Based on GeNorm evaluation, RPL32 and 
HNRNPH1 expressions were selected for normalisation. 
Ranking of reference genes was not reported for the dif-
ferent anatomical regions. This paper is, apart from the 
specific set of differentially expressed genes, a landmark 
since it is one of the very few papers addressing the issue 
of gene expression normalisation in canine brain tissue.
Table 1 GeNorm ranking of reference genes in order of their expression stability for specific brain regions
Decreasing from top to bottom; the most stable genes are depicted on top
All average of all areas
Frontal lobe Parietal lobe Temporal lobe Occipital lobe Hippocampus Cerebellum Thalamus All
HMBS HMBS RPL13A HMBS RPL13A HMBS GAPDH HMBS
HPRT YWHAZ RPS5 HPRT RPS19 SDHA HPRT GAPDH
GAPDH SDHA HPRT SDHA RPS5 YWHAZ RPL13A HPRT
RPS5 GUSB GAPDH B2M B2M GAPDH RPS5 RPL13A
RPL13A GAPDH YWHAZ YWHAZ HMBS B2M RPS19 SDHA
RPS19 B2M RPS19 GAPDH GAPDH GUSB YWHAZ RPS5
GUSB RPS19 HMBS RPL13A SDHA HPRT SDHA RPS19
SDHA HPRT SDHA RPS19 HPRT RPS19 HMBS YWHAZ
YWHAZ RPS5 GUSB RPS5 GUSB RPL13A GUSB B2M
B2M RPL13A B2M GUSB YWHAZ RPS5 B2M GUSB
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Fig. 1 Average expression stability (M) of remaining reference genes during subsequent elimination of the least stable gene in different brain 
regions. M was calculated for all genes and the gene with the highest M-value was excluded in the next calculation round. Results are based on 
analysis of 7 brain areas of 7 dogs each: LF lobus frontalis, LP lobus parietalis, LT lobus temporalis, LO lobus occipitalis, H hippocampus, C cerebellum, 
T thalamus, All average of all areas
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Park et  al. selected endogenous control genes for 
whole brain and different canine brain regions (fore-
brain divided in cerebrum and diencephalon, hindbrain 
including metencephalon) [22]. Results of RT-qPCR stud-
ies were analysed by GeNorm, NormFinder and Best-
Keeper software programs. However analyses were based 
on tissue samples from only two 12 month-old male Bea-
gles, with most of the specific anatomical regions col-
lected in only one dog. RPS5 was found to be the most 
stably expressed control gene for whole brain tissue.
In the present research we studied expression of ten 
frequently used reference genes in seven healthy dogs of 
diverse breeds, both male and female in a wide age range 
(4 months to 9 years). Seven different brain regions (fron-
tal lobe, parietal lobe, occipital lobe and temporal lobe, 
thalamus, hippocampus and cerebellum) relevant for 
brain disorders like epilepsy, Alzheimer’s disease, psycho-
logical and movement disorders were evaluated. “MIQE” 
guidelines [24] were followed to guarantee the technical 
quality of this research and allow assessment of experi-
mental design. Data analysis was performed using two 
independent freeware platforms. Both GeNorm and Nor-
mFinder determined HMBS and the traditional reference 
gene GAPDH to be among the most stably expressed 
internal control genes. However expression stabilities 
of the seven genes next in rank are not far apart. This is 
LF LP L
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Fig. 2 Determination of the optimum number of reference genes for normalisation of RT-qPCR data. The GeNorm program calculates the nor-
malisation factor (NF) for a given number of genes (n) and defines the pairwise variation (V) between the sequential normalisation factors NFn and 
NFn+1. For example V2/3 represents the variation in NFs using the two versus three most stable control genes. A low V value indicates little variation, 
implying that adding the extra gene has no significant effect. Pairwise variation (V) < 0.15 is regarded to result in valid normalisation. Using this 
cut-off value all evaluated brain regions require only two reference genes for accurate normalisation. Results are based on analysis of 7 brain areas 
of 7 dogs each: LF lobus frontalis, LP lobus parietalis, LT lobus temporalis, LO lobus occipitalis, H hippocampus, C cerebellum, T thalamus, All average 
of all areas
Table 2 Ranking of  reference genes based on  GeNorm 
and  NormFinder calculations, averages of  all evaluated 
brain areas
A low stability value in NormFinder calculations corresponds with high 
expression stability. The GeNorm program doesn’t distinguish between the two 
most stably expressed genes (HMBS and HRPT) because gene ratios are required 
for the calculations
Ranking order GeNorm NormFinder NormFinder stability value
1 most stable HMBS HMBS 0.005




6 RPS5 RPS5 0.008
7 RPS19 B2M
8 YWHAZ RPL13 0.009
9 B2M SDHA
10 least stable GUSB YWHAZ 0.025
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demonstrated by the same or only marginal higher stabil-
ity values in NormFinder calculations and the only gentle 
slope of the “all” curve from the point of nine remain-
ing reference genes in Fig. 1. The GeNorm manual sug-
gests a cut-off M-value of 1.5, indicating that genes with 
M-values lower than this limit are stable enough to be 
used as reference gene. M-values of the nine most sta-
bly expressed genes evaluated in this study were all well 
under this 1.5 limit, with HMBS and GAPDH reaching a 
value of 0.24. Likewise stability values of these genes cal-
culated by NormFinder were low (range 0.005–0.009). 
The combination of two genes (HMBS and GAPDH/
HRTP/RPS19/GUSB) further improved the stability value 
to 0.004. The GeNorm program calculated that using 
only two reference genes (HMBS and GAPDH) is suf-
ficient for valid normalisation. However the minimum 
use of three stable control genes is recommended by the 
GeNorm programme developers [24, 27].
Although all candidate reference genes evaluated in the 
present study were included in the research of Park et al., 
results differed considerably. Park et  al. reported RPS5, 
which was also included in the study of Vage et al., to be 
the most stable control gene for whole brain tissue. In our 
study it was assigned to the genes with relatively moderate 
stable expression. Conversely HMBS and GAPDH which 
we identified as the most stable genes were only average 
performers in the study by Park et al. B2M and YWHAZ 
showed relatively poor expression stability in both studies. 
Vage et  al. identified RPL32 and HNRNPH1 as the most 
appropriate reference genes for canine brain tissue. Both 
genes were tested by Park et al. as well, but didn’t achieve 
top ranking. These inconsistencies may be caused by the 
various anatomical regions analysed, the small number of 
dogs in the study by Park et al. or different experimental 
settings. Another contributing factor may be that expres-
sion stabilities of some candidate control genes were 
found to be close to each other. As a result, only small 
variations in calculated expression stability can cause sub-
stantial changes in ranking order. This is illustrated by the 
fact that in our NormFinder calculations the genes ranked 
second to fifth all have the same stability value. As a con-
sequence ranking is rather arbitrary.
Comparing studies on brain reference genes in 
humans, dogs, rats and mice is difficult because of dif-
ferent sets of candidate genes selected and variable 
experimental design [34–39]. Results vary between and 
sometimes within species and brain regions evaluated. 
In a cross-species reference gene evaluation in pituitary 
samples from humans, mice and dogs van Rijn et al. dem-
onstrated that the expression stability varied between the 
three species [18].
Both Wang [38] and Johansson [34] paper identified 
IPO8 and POLR2A as the two most stably expressed 
reference genes in human cerebral cortex (regions evalu-
ated respectively parietal lobe and motor cortex) out of a 
large number of candidates (respectively 24 and 15). In 
Johansson paper brain cortices of chronic alcoholics and 
controls were included, whereas the research of Wang 
et  al. evaluated brain tissue without pre-existing neuro-
logical pathology.
Together these papers clearly underline that the most 
stably expressed reference genes, and the number needed 
for accurate normalisation, vary among different experi-
mental procedures, even if similar tissues of the same 
species are included. The importance of using validated 
transparent research protocols and appropriate inter-
nal control genes has been highlighted in several papers 
[14, 19, 24, 31]. Still numerous studies on RT-qPCR 
experiments using not validated and/or only one inter-
nal control gene have been published. A recent study 
analysed 1700 scientific papers that used RT-qPCR as a 
gene expression tool [40]. The vast majority of these 1700 
papers did not report adequately on the details of the 
expression measurements. As little as around 10 % imple-
mented the MIQE-guidelines. What’s most worrisome is 
that the number of reference genes included and the use 
of validated reference genes to normalise gene expression 
was negatively correlated with the journal’s impact factor 
[40].
Conclusion
In order for RT-qPCR studies to be of clinical relevance 
it is of utmost importance that data are presented in a 
way that permits proper data comparison and experi-
mental repetition. Furthermore accurate normalisation 
of data using stably expressed reference genes is indis-
pensable. However expression of reference genes has 
been shown to vary among species, tissues and experi-
mental settings. Therefore systematic reference gene 
stability evaluation must be an integral part of the exper-
imental design.
Still the first step in identifying these reference genes 
is the selection of likely candidates. Wang [38] and the 
Johansson [34] papers prove that established tissue 
specific internal control genes can be very good candi-
dates for other research projects on the same tissue. We 
conclude that HMBS, GAPDH and HPRT are excellent 
candidate reference genes for canine brain RT-qPCR 
studies.
Additional files
Additional file 1: Table S1. Details of primers evaluated in this research: 
primer sequences, product sizes, exonic locations, optimal melting tem-
peratures and GenBank accession numbers.
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